framycetin has been researched along with Budd-Chiari Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abramsky, O; Goldschmidt, Z | 1 |
| Aldrete, JS; Feinberg, JH; Summerskill, WH; Thorsell, F | 1 |
2 other study(ies) available for framycetin and Budd-Chiari Syndrome
| Article | Year |
|---|---|
Treatment and prevention of acute hepatic encephalopathy by intravenous levodopa.
Topics: Adult; Aged; Blood Transfusion; Brain; Budd-Chiari Syndrome; Dihydroxyphenylalanine; Drug Therapy, Combination; Electroencephalography; Female; Gastrointestinal Hemorrhage; Hepatic Encephalopathy; Humans; Liver Cirrhosis; Liver Diseases; Male; Middle Aged; Neomycin; Vena Cava, Inferior | 1974 |
Effects of urease inhibition in hyperammonemia: clinical and experimental studies with acetohydroxamic acid.
Topics: Aged; Ammonia; Animals; Bilirubin; Budd-Chiari Syndrome; Dogs; Fasting; Female; Hepatic Encephalopathy; Hepatitis; Humans; Hydroxamic Acids; Liver Cirrhosis; Liver Diseases; Male; Metabolic Diseases; Middle Aged; Necrosis; Neomycin; Portacaval Shunt, Surgical; Serum Albumin; Urea; Urease | 1968 |